Response to Letter to the Editor concerning "Progression-free survival (PFS) in oncology: Caveat emptor!

Publikation: Bidrag til tidsskriftKommentar/debatForskning

OriginalsprogEngelsk
TidsskriftBasic & Clinical Pharmacology & Toxicology
Vol/bind124
Udgave nummer3
Sider (fra-til)239
Antal sider1
ISSN1742-7835
DOI
StatusUdgivet - mar. 2019

Citer dette

@article{53f10ac9b14a44a2813f13b20e4e47cc,
title = "Response to Letter to the Editor concerning {"}Progression-free survival (PFS) in oncology: Caveat emptor!",
author = "Bergmann, {Troels K} and Christensen, {Mette Marie H} and Haastrup, {Maija Bruun} and Per Damkier",
year = "2019",
month = "3",
doi = "10.1111/bcpt.13200",
language = "English",
volume = "124",
pages = "239",
journal = "Basic & Clinical Pharmacology & Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Response to Letter to the Editor concerning "Progression-free survival (PFS) in oncology: Caveat emptor!

AU - Bergmann, Troels K

AU - Christensen, Mette Marie H

AU - Haastrup, Maija Bruun

AU - Damkier, Per

PY - 2019/3

Y1 - 2019/3

U2 - 10.1111/bcpt.13200

DO - 10.1111/bcpt.13200

M3 - Comment/debate

VL - 124

SP - 239

JO - Basic & Clinical Pharmacology & Toxicology

JF - Basic & Clinical Pharmacology & Toxicology

SN - 1742-7835

IS - 3

ER -